However, in contrast to the cases described above, in metastatic melanoma and aggressive breast cancer cells, ADAR1 silence or deletion can also control oncogenic or suppress the biogenesis of tumor miRNAs to enhance their malignant properties [117–120]. Here, ADAR is linked to breast cancer.